Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2020
SIETES contiene 93096 citas

 
 
 1 a 20 de 212 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Se recomienda no iniciar nuevos tratamientos con ?Monoferro® (hierro-isomaltósido) debido al riesgo de reacciones graves de hipersensibilidad. Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2017:1-2. [Ref.ID 101915]
2. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
3.Tiene citas relacionadas
Wang C, Wong S, Graham DJ. Risk of anaphylaxis with intravenous iron products. JAMA 2016;315:2232-3. [Ref.ID 100367]
4.Tiene citas relacionadas
DeLoughery TG. Risk of anaphylaxis with intravenous iron products. JAMA 2016;315:2232. [Ref.ID 100366]
5. Cita con resumen
Travasso C. Journal article questions the use of ayurvedic therapies for diabetes. BMJ 2016;353:i1990. [Ref.ID 100351]
6.Tiene citas relacionadas Cita con resumen
Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S, Erickson SB. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Renal Failure 2015;37:1237-41. [Ref.ID 99742]
7. Cita con resumen
Cheungpasitporn W, Thongprayoon C, Mao MA, Srivali N, Ungprasert P, Varothai N, Sanguankeo A, Kittanamongkolchai W, Erickson SB. Hypomagnesaemia linked to depression: a systematic review and meta-analysis. Internal Medicine Journal 2015;45:436-40. [Ref.ID 99741]
8.Tiene citas relacionadas Cita con resumen
Wang C, Graham DJ, Kane RC, Xie D, Wemecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu T-C, Limb S, Worrall C, Kelman JA, Reichman ME. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015;314:2062-8. [Ref.ID 99687]
9. Cita con resumen
Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med 2015;373:1649-58. [Ref.ID 99629]
10. Cita con resumen
Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, Mozersky RP, Budnitz DS. Emergency department visits for adverse events related to dietary supplements. N Engl J Med 2015;373:1531-40. [Ref.ID 99589]
11. Cita con resumen
Chinthapalli K. The billion dollar business of being smart. BMJ 2015;351:h4829. [Ref.ID 99542]
12.Tiene citas relacionadas Cita con resumen
Shine B, McKnight RF, Leaver L, Geddes JR. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. Lancet 2015;386:461-8. [Ref.ID 99217]
13. Cita con resumen
Fernández-Fernández FJ, Martín-Fernández A. Parenteral iron as a cause of hypophosphataemia. BMJ 2014;349:g4616. [Ref.ID 97762]
14. Cita con resumen
Anónimo. Ferric carboxymaltose (Ferinject) for iron-deficiency anaemia. NPS Radar 2014:1. [Ref.ID 97755]
16.Enlace a cita original Cita con resumen
Kristal AR, Darke AK, Morris S, Tangen CM, Goodman PJ, Thompson IM, Meyskens jr FL, Goodman GE, Minasian LM, Parnes HL, Lippman SM, Klein EA. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst 2014;106:456. [Ref.ID 97156]
17.Tiene citas relacionadas Cita con resumen
18. Cita con resumen
Anónimo. New recommendations for intravenous iron-containing medicines. European Union. WHO Drug Information 2013;27:222. [Ref.ID 96292]
20.Tiene citas relacionadas
McIntyre LA, Timmouth A, Fergusson D. Intravenous iron therapy for treatment of anemia. BMJ 2013;347:7. [Ref.ID 96201]
Seleccionar todas
 
 1 a 20 de 212 siguiente >>